Skip to main content
TipRanks
Go Ultimate75% OFF

Starling Oncology Institute (STLN) Q4 2023 Earnings Report

213 Followers

STLN Q4 2023 EPS Results

Actual EPS
-$0.21
Consensus EPS
-$0.11
Beat/Miss
Missed by -$0.10
One Year Ago EPS
-$0.16

STLN Q4 2023 Revenue Results

Actual Revenue
$85.79M
Expected Revenue
$82.04M
Beat/Miss
Beat by +$3.75M
YoY Revenue Growth
+20.11%

Earnings Announcement Details

Quarter
Q4 2023
Date
03/27/2024
Time
After Close
Conference Call
Wednesday, March 27, 2024
STLN Upcoming Earnings

Starling Oncology Institute's next earnings date is estimated for March 11, 2027, based on past reporting schedules.

Q4 2023 Earnings Call Audio

STLN Q4 2023 Earnings Call
0:00 / 0:00

Q4 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

STLN Earnings History

STLN earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 11, 20272026 (Q4)-0.04--0.06――
Nov 05, 20262026 (Q3)-0.05-0.13-0.147.14% (+0.01)
Aug 06, 20262026 (Q2)-0.06-0.08-0.1546.67% (+0.07)
May 07, 20262026 (Q1)-0.09-0.02-0.2190.48% (+0.19)
Mar 12, 20262025 (Q4)-0.09-0.06-0.1457.14% (+0.08)
Nov 13, 20252025 (Q3)-0.11-0.14-0.1822.22% (+0.04)
Aug 13, 20252025 (Q2)-0.12-0.15-0.1711.76% (+0.02)
May 14, 20252025 (Q1)―-0.21-0.224.55% (+0.01)
Mar 24, 20252024 (Q4)―-0.14-0.2133.33% (+0.07)
Nov 13, 20242024 (Q3)―-0.18-0.195.26% (+0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed